Irina Petrache
Concepts (589)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Emphysema | 36 | 2026 | 277 | 9.500 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 25 | 2026 | 928 | 5.030 |
Why?
| | alpha 1-Antitrypsin | 16 | 2026 | 104 | 4.970 |
Why?
| | Ceramides | 24 | 2025 | 117 | 4.960 |
Why?
| | Lung Injury | 14 | 2026 | 262 | 4.590 |
Why?
| | Lung | 57 | 2026 | 4141 | 4.520 |
Why?
| | Apoptosis | 41 | 2026 | 2454 | 4.000 |
Why?
| | Endothelial Cells | 26 | 2026 | 886 | 3.860 |
Why?
| | Smoking | 30 | 2020 | 1483 | 3.750 |
Why?
| | Cigarette Smoking | 8 | 2022 | 103 | 3.160 |
Why?
| | Smoke | 12 | 2021 | 148 | 2.860 |
Why?
| | Electronic Nicotine Delivery Systems | 7 | 2023 | 112 | 2.650 |
Why?
| | Emphysema | 10 | 2023 | 100 | 2.310 |
Why?
| | Vaping | 4 | 2026 | 81 | 2.300 |
Why?
| | alpha 1-Antitrypsin Deficiency | 9 | 2026 | 61 | 2.280 |
Why?
| | Sphingomyelin Phosphodiesterase | 7 | 2025 | 27 | 2.280 |
Why?
| | Sphingolipids | 8 | 2025 | 83 | 2.270 |
Why?
| | Pulmonary Alveoli | 15 | 2018 | 389 | 1.990 |
Why?
| | Macrophages, Alveolar | 5 | 2021 | 377 | 1.950 |
Why?
| | Hypertension, Pulmonary | 11 | 2026 | 1977 | 1.770 |
Why?
| | Acute Lung Injury | 4 | 2025 | 312 | 1.740 |
Why?
| | Animals | 92 | 2026 | 38417 | 1.380 |
Why?
| | Autophagy | 8 | 2026 | 291 | 1.300 |
Why?
| | Tobacco Products | 5 | 2021 | 90 | 1.290 |
Why?
| | Endothelium, Vascular | 11 | 2023 | 959 | 1.280 |
Why?
| | Mice | 59 | 2026 | 18493 | 1.280 |
Why?
| | Oxidative Stress | 14 | 2026 | 1368 | 1.260 |
Why?
| | Signal Transduction | 21 | 2026 | 5272 | 1.240 |
Why?
| | Microvessels | 4 | 2021 | 98 | 1.220 |
Why?
| | Cells, Cultured | 24 | 2026 | 4170 | 1.150 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2017 | 1225 | 1.090 |
Why?
| | Alveolar Epithelial Cells | 3 | 2018 | 121 | 1.040 |
Why?
| | Mice, Inbred C57BL | 28 | 2025 | 6042 | 1.030 |
Why?
| | Disease Models, Animal | 18 | 2026 | 4605 | 1.030 |
Why?
| | Neovascularization, Physiologic | 4 | 2026 | 197 | 1.030 |
Why?
| | MicroRNAs | 3 | 2026 | 695 | 1.010 |
Why?
| | Pneumonia | 5 | 2021 | 636 | 0.940 |
Why?
| | Lipopolysaccharides | 5 | 2025 | 863 | 0.940 |
Why?
| | Caspase 3 | 7 | 2016 | 242 | 0.930 |
Why?
| | Receptors, Estrogen | 3 | 2014 | 406 | 0.910 |
Why?
| | Pulmonary Artery | 10 | 2022 | 1132 | 0.900 |
Why?
| | Membrane Proteins | 5 | 2022 | 1171 | 0.880 |
Why?
| | Rats | 23 | 2026 | 5613 | 0.860 |
Why?
| | Tobacco Smoke Pollution | 4 | 2018 | 227 | 0.860 |
Why?
| | Inflammation | 9 | 2025 | 2921 | 0.850 |
Why?
| | Humans | 103 | 2026 | 147306 | 0.850 |
Why?
| | Adipose Tissue | 5 | 2017 | 646 | 0.850 |
Why?
| | Hypoxia | 6 | 2020 | 1209 | 0.840 |
Why?
| | Up-Regulation | 10 | 2020 | 848 | 0.830 |
Why?
| | Endothelium | 4 | 2023 | 119 | 0.820 |
Why?
| | Endocytosis | 3 | 2016 | 168 | 0.810 |
Why?
| | Epithelial Cells | 11 | 2026 | 1141 | 0.720 |
Why?
| | Vascular System Injuries | 1 | 2023 | 83 | 0.720 |
Why?
| | Mice, Knockout | 12 | 2025 | 3153 | 0.690 |
Why?
| | Rats, Sprague-Dawley | 15 | 2026 | 2542 | 0.680 |
Why?
| | Phagocytosis | 3 | 2021 | 299 | 0.680 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 4 | 0.680 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 4 | 0.680 |
Why?
| | Lysophospholipase | 1 | 2021 | 10 | 0.670 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2020 | 17 | 0.620 |
Why?
| | Glucosylceramides | 1 | 2019 | 7 | 0.610 |
Why?
| | Immunoglobulins | 1 | 2020 | 163 | 0.600 |
Why?
| | Translocation, Genetic | 1 | 2020 | 126 | 0.600 |
Why?
| | Proteomics | 2 | 2026 | 1205 | 0.600 |
Why?
| | Hyaluronic Acid | 2 | 2020 | 226 | 0.600 |
Why?
| | Estradiol | 3 | 2018 | 515 | 0.580 |
Why?
| | Glycoproteins | 1 | 2021 | 358 | 0.570 |
Why?
| | Bronchoalveolar Lavage Fluid | 8 | 2026 | 641 | 0.570 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2019 | 22 | 0.570 |
Why?
| | Enzyme Inhibitors | 4 | 2018 | 822 | 0.560 |
Why?
| | Macrophages | 4 | 2021 | 1530 | 0.560 |
Why?
| | Influenza, Human | 2 | 2022 | 634 | 0.550 |
Why?
| | Alpha-Globulins | 1 | 2018 | 20 | 0.550 |
Why?
| | Lysosomes | 2 | 2021 | 133 | 0.550 |
Why?
| | Heterocyclic Compounds | 1 | 2018 | 23 | 0.540 |
Why?
| | Xeroderma Pigmentosum | 1 | 2018 | 9 | 0.540 |
Why?
| | Neoplasm Proteins | 5 | 2019 | 445 | 0.540 |
Why?
| | Sphingosine | 5 | 2015 | 47 | 0.530 |
Why?
| | Antibodies, Neutralizing | 2 | 2019 | 345 | 0.530 |
Why?
| | Lung Diseases | 4 | 2025 | 787 | 0.530 |
Why?
| | Oncostatin M | 1 | 2017 | 6 | 0.530 |
Why?
| | Sphingosine N-Acyltransferase | 2 | 2018 | 6 | 0.520 |
Why?
| | Metformin | 1 | 2021 | 329 | 0.520 |
Why?
| | Male | 48 | 2026 | 73954 | 0.520 |
Why?
| | Cell Movement | 5 | 2026 | 966 | 0.520 |
Why?
| | Thorax | 2 | 2022 | 51 | 0.510 |
Why?
| | RNA-Binding Proteins | 5 | 2019 | 451 | 0.510 |
Why?
| | Multiprotein Complexes | 1 | 2018 | 172 | 0.480 |
Why?
| | Cell Death | 4 | 2019 | 383 | 0.480 |
Why?
| | Hypertrophy, Right Ventricular | 4 | 2026 | 152 | 0.480 |
Why?
| | Scavenger Receptors, Class B | 1 | 2015 | 14 | 0.450 |
Why?
| | DNA Repair | 1 | 2018 | 256 | 0.450 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 73 | 0.450 |
Why?
| | Telemetry | 1 | 2015 | 40 | 0.440 |
Why?
| | Genetic Predisposition to Disease | 3 | 2020 | 2458 | 0.440 |
Why?
| | Cytokines | 9 | 2019 | 2087 | 0.440 |
Why?
| | Cosmic Radiation | 1 | 2014 | 5 | 0.440 |
Why?
| | ADAM Proteins | 3 | 2022 | 65 | 0.430 |
Why?
| | DNA Damage | 1 | 2018 | 440 | 0.430 |
Why?
| | Female | 37 | 2026 | 80081 | 0.430 |
Why?
| | Mice, Transgenic | 8 | 2022 | 2197 | 0.430 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 69 | 0.430 |
Why?
| | Oxidoreductases | 4 | 2011 | 91 | 0.420 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2013 | 269 | 0.420 |
Why?
| | Transcytosis | 1 | 2014 | 7 | 0.420 |
Why?
| | Palmitic Acids | 1 | 2014 | 10 | 0.410 |
Why?
| | Receptors, Lysosphingolipid | 2 | 2014 | 13 | 0.410 |
Why?
| | Alginates | 1 | 2014 | 60 | 0.410 |
Why?
| | Caspase Inhibitors | 3 | 2011 | 81 | 0.400 |
Why?
| | Enzyme Activation | 8 | 2015 | 762 | 0.400 |
Why?
| | Nicotinic Agonists | 1 | 2015 | 135 | 0.400 |
Why?
| | Cell Proliferation | 9 | 2020 | 2529 | 0.400 |
Why?
| | Thoracic Vertebrae | 1 | 2014 | 90 | 0.400 |
Why?
| | Spinal Injuries | 1 | 2014 | 61 | 0.400 |
Why?
| | Influenza A virus | 2 | 2026 | 119 | 0.390 |
Why?
| | Stem Cell Transplantation | 2 | 2015 | 189 | 0.390 |
Why?
| | Trypsin Inhibitors | 2 | 2017 | 7 | 0.370 |
Why?
| | Tracheostomy | 1 | 2014 | 143 | 0.370 |
Why?
| | Interleukin-6 | 1 | 2016 | 784 | 0.360 |
Why?
| | Lysophospholipids | 5 | 2015 | 80 | 0.360 |
Why?
| | Nicotine | 1 | 2015 | 336 | 0.360 |
Why?
| | Pseudomonas Infections | 1 | 2014 | 231 | 0.360 |
Why?
| | Cystic Fibrosis | 2 | 2014 | 1171 | 0.340 |
Why?
| | Biomarkers | 9 | 2026 | 4354 | 0.340 |
Why?
| | Estrogens | 1 | 2014 | 368 | 0.330 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 397 | 0.330 |
Why?
| | Metabolomics | 5 | 2018 | 737 | 0.330 |
Why?
| | Photons | 1 | 2011 | 67 | 0.330 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2021 | 57 | 0.330 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 323 | 0.320 |
Why?
| | Stress, Physiological | 1 | 2014 | 445 | 0.320 |
Why?
| | Cell Differentiation | 2 | 2018 | 2054 | 0.320 |
Why?
| | Phenotype | 8 | 2026 | 3216 | 0.310 |
Why?
| | Virus Diseases | 2 | 2023 | 218 | 0.310 |
Why?
| | Adult Stem Cells | 1 | 2010 | 40 | 0.310 |
Why?
| | Exercise Therapy | 1 | 2015 | 489 | 0.310 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2014 | 2030 | 0.310 |
Why?
| | Pancreatic Elastase | 2 | 2021 | 54 | 0.300 |
Why?
| | Hemodynamics | 1 | 2015 | 1127 | 0.300 |
Why?
| | Caspases | 3 | 2011 | 233 | 0.300 |
Why?
| | Ventricular Function, Right | 2 | 2026 | 300 | 0.290 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2024 | 187 | 0.290 |
Why?
| | Superoxide Dismutase | 3 | 2020 | 308 | 0.280 |
Why?
| | Fingolimod Hydrochloride | 3 | 2022 | 40 | 0.280 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2021 | 456 | 0.270 |
Why?
| | Sphingomyelins | 3 | 2025 | 22 | 0.270 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 342 | 0.270 |
Why?
| | Vascular Remodeling | 4 | 2025 | 209 | 0.270 |
Why?
| | Mass Spectrometry | 4 | 2018 | 728 | 0.260 |
Why?
| | Cricetinae | 2 | 2026 | 305 | 0.260 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 536 | 0.260 |
Why?
| | Fibrinolysin | 1 | 2007 | 19 | 0.250 |
Why?
| | Heart | 1 | 2011 | 628 | 0.250 |
Why?
| | Predictive Value of Tests | 3 | 2026 | 2133 | 0.250 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1488 | 0.250 |
Why?
| | Transcription Factors | 2 | 2012 | 1747 | 0.250 |
Why?
| | Estrogen Receptor alpha | 2 | 2026 | 154 | 0.250 |
Why?
| | Mesocricetus | 1 | 2026 | 52 | 0.240 |
Why?
| | Heart Ventricles | 2 | 2026 | 767 | 0.240 |
Why?
| | RNA, Small Interfering | 3 | 2018 | 643 | 0.240 |
Why?
| | Electric Impedance | 3 | 2015 | 108 | 0.240 |
Why?
| | Thrombin | 1 | 2007 | 174 | 0.230 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 4 | 2012 | 109 | 0.230 |
Why?
| | Gene Expression Regulation | 5 | 2020 | 2625 | 0.230 |
Why?
| | ADAM17 Protein | 2 | 2017 | 42 | 0.220 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 182 | 0.220 |
Why?
| | Middle Aged | 12 | 2026 | 36821 | 0.220 |
Why?
| | Leukocytes | 3 | 2022 | 301 | 0.220 |
Why?
| | Cell Adhesion | 2 | 2020 | 451 | 0.220 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 374 | 0.210 |
Why?
| | Forced Expiratory Volume | 1 | 2026 | 451 | 0.210 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2015 | 125 | 0.210 |
Why?
| | Caspase 6 | 2 | 2016 | 3 | 0.210 |
Why?
| | Caspase 7 | 2 | 2016 | 22 | 0.210 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 669 | 0.210 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 25 | 0.200 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2791 | 0.200 |
Why?
| | Capillary Permeability | 2 | 2015 | 132 | 0.200 |
Why?
| | Receptors, CXCR3 | 2 | 2013 | 17 | 0.190 |
Why?
| | Monocytes | 4 | 2023 | 539 | 0.190 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2003 | 19 | 0.190 |
Why?
| | Biomedical Technology | 1 | 2024 | 50 | 0.190 |
Why?
| | Homeostasis | 3 | 2018 | 651 | 0.190 |
Why?
| | Pulmonary Medicine | 1 | 2024 | 78 | 0.190 |
Why?
| | Cell Culture Techniques | 2 | 2019 | 375 | 0.190 |
Why?
| | rho GTP-Binding Proteins | 1 | 2003 | 56 | 0.190 |
Why?
| | Cell Line | 4 | 2017 | 2832 | 0.190 |
Why?
| | Respiratory System | 1 | 2024 | 150 | 0.180 |
Why?
| | Oxygen Consumption | 2 | 2022 | 721 | 0.180 |
Why?
| | Cell Adhesion Molecules | 2 | 2015 | 182 | 0.180 |
Why?
| | Primary Cell Culture | 2 | 2013 | 173 | 0.170 |
Why?
| | Monocrotaline | 2 | 2026 | 34 | 0.170 |
Why?
| | X-Ray Microtomography | 2 | 2022 | 114 | 0.170 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1266 | 0.170 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 264 | 0.170 |
Why?
| | Congresses as Topic | 1 | 2023 | 227 | 0.170 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 9 | 0.170 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 8 | 0.170 |
Why?
| | Chitinases | 1 | 2021 | 9 | 0.170 |
Why?
| | Flow Cytometry | 4 | 2015 | 1172 | 0.170 |
Why?
| | CD11 Antigens | 1 | 2021 | 30 | 0.170 |
Why?
| | CD11b Antigen | 1 | 2021 | 60 | 0.170 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2021 | 41 | 0.170 |
Why?
| | Kinetics | 3 | 2015 | 1569 | 0.170 |
Why?
| | Lectins | 1 | 2021 | 44 | 0.170 |
Why?
| | Cytoskeleton | 3 | 2011 | 193 | 0.170 |
Why?
| | Cell Size | 1 | 2021 | 94 | 0.170 |
Why?
| | Societies, Medical | 2 | 2023 | 914 | 0.160 |
Why?
| | Microtubules | 1 | 2003 | 267 | 0.160 |
Why?
| | Protein Inhibitors of Activated STAT | 1 | 2020 | 6 | 0.160 |
Why?
| | Blotting, Western | 4 | 2011 | 1186 | 0.160 |
Why?
| | Endothelial Progenitor Cells | 1 | 2020 | 20 | 0.160 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2020 | 26 | 0.160 |
Why?
| | Inhalation Exposure | 1 | 2021 | 103 | 0.160 |
Why?
| | Integrin beta1 | 1 | 2020 | 33 | 0.160 |
Why?
| | Receptors, CXCR4 | 2 | 2018 | 91 | 0.160 |
Why?
| | Risk Factors | 5 | 2024 | 11017 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 300 | 0.160 |
Why?
| | Stem Cell Niche | 1 | 2020 | 58 | 0.160 |
Why?
| | Lactic Acid | 1 | 2022 | 295 | 0.160 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2020 | 82 | 0.150 |
Why?
| | Tobacco Smoking | 1 | 2020 | 28 | 0.150 |
Why?
| | Sirolimus | 1 | 2021 | 283 | 0.150 |
Why?
| | Dronabinol | 1 | 2023 | 251 | 0.150 |
Why?
| | Oxidants | 2 | 2011 | 99 | 0.150 |
Why?
| | Stromal Cells | 2 | 2017 | 123 | 0.150 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2020 | 83 | 0.150 |
Why?
| | Ischemia | 2 | 2018 | 424 | 0.150 |
Why?
| | Cell Membrane | 3 | 2013 | 711 | 0.150 |
Why?
| | Biological Assay | 2 | 2021 | 134 | 0.150 |
Why?
| | Ventricular Remodeling | 3 | 2026 | 283 | 0.150 |
Why?
| | Collagen Type V | 2 | 2009 | 4 | 0.150 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2019 | 17 | 0.140 |
Why?
| | Exercise Test | 1 | 2022 | 636 | 0.140 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2020 | 376 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2017 | 3660 | 0.140 |
Why?
| | Serine C-Palmitoyltransferase | 3 | 2008 | 8 | 0.140 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2020 | 199 | 0.140 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2014 | 178 | 0.140 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2013 | 163 | 0.140 |
Why?
| | Eosinophils | 1 | 2021 | 319 | 0.140 |
Why?
| | Cell Survival | 3 | 2018 | 1111 | 0.140 |
Why?
| | Paclitaxel | 2 | 2014 | 261 | 0.140 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 212 | 0.140 |
Why?
| | Fatty Acids | 1 | 2022 | 461 | 0.140 |
Why?
| | beta Catenin | 1 | 2020 | 254 | 0.140 |
Why?
| | Benzylamines | 1 | 2018 | 44 | 0.140 |
Why?
| | Databases, Chemical | 1 | 2018 | 9 | 0.140 |
Why?
| | Parenchymal Tissue | 1 | 2018 | 4 | 0.140 |
Why?
| | Imipramine | 1 | 2018 | 11 | 0.140 |
Why?
| | Estrogen Receptor beta | 1 | 2018 | 40 | 0.140 |
Why?
| | Hot Temperature | 1 | 2021 | 396 | 0.130 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 44 | 0.130 |
Why?
| | Gene Expression | 2 | 2021 | 1481 | 0.130 |
Why?
| | Chemokine CXCL12 | 1 | 2018 | 86 | 0.130 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 138 | 0.130 |
Why?
| | Morphine | 2 | 2009 | 169 | 0.130 |
Why?
| | Oxygen | 2 | 2014 | 998 | 0.130 |
Why?
| | Cell Hypoxia | 4 | 2020 | 249 | 0.130 |
Why?
| | Carbon Monoxide | 1 | 2018 | 82 | 0.130 |
Why?
| | Aged | 6 | 2026 | 26516 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 487 | 0.130 |
Why?
| | Neovascularization, Pathologic | 2 | 2012 | 287 | 0.130 |
Why?
| | Leukocyte Elastase | 1 | 2017 | 75 | 0.130 |
Why?
| | Disease Outbreaks | 1 | 2020 | 420 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2020 | 566 | 0.130 |
Why?
| | THP-1 Cells | 1 | 2016 | 19 | 0.120 |
Why?
| | Adult | 10 | 2022 | 41406 | 0.120 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2011 | 288 | 0.120 |
Why?
| | Bone Marrow | 1 | 2018 | 310 | 0.120 |
Why?
| | Transcriptome | 3 | 2018 | 1059 | 0.120 |
Why?
| | Adipocytes | 1 | 2018 | 223 | 0.120 |
Why?
| | Spinal Cord | 2 | 2009 | 383 | 0.120 |
Why?
| | High-Intensity Interval Training | 1 | 2016 | 45 | 0.120 |
Why?
| | Sleep Apnea Syndromes | 1 | 2017 | 98 | 0.120 |
Why?
| | Time Factors | 3 | 2018 | 7173 | 0.120 |
Why?
| | Protein Kinases | 1 | 2018 | 312 | 0.110 |
Why?
| | Protein Binding | 3 | 2018 | 2249 | 0.110 |
Why?
| | Bronchi | 1 | 2017 | 263 | 0.110 |
Why?
| | Plasma | 1 | 2017 | 224 | 0.110 |
Why?
| | Pandemics | 2 | 2021 | 1720 | 0.110 |
Why?
| | I-kappa B Proteins | 2 | 2013 | 75 | 0.110 |
Why?
| | Mice, 129 Strain | 2 | 2012 | 85 | 0.110 |
Why?
| | Lung Transplantation | 2 | 2009 | 338 | 0.110 |
Why?
| | Delivery of Health Care | 1 | 2022 | 951 | 0.110 |
Why?
| | Asthma | 2 | 2020 | 1805 | 0.110 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 393 | 0.110 |
Why?
| | Ventricular Pressure | 1 | 2015 | 52 | 0.110 |
Why?
| | Actins | 3 | 2018 | 428 | 0.110 |
Why?
| | Neutrophils | 1 | 2021 | 1135 | 0.110 |
Why?
| | Binding, Competitive | 1 | 2015 | 185 | 0.110 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.110 |
Why?
| | Myelopoiesis | 1 | 2015 | 10 | 0.110 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2015 | 60 | 0.110 |
Why?
| | Cathepsin E | 1 | 2014 | 1 | 0.110 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 143 | 0.110 |
Why?
| | Cell Membrane Permeability | 1 | 2015 | 89 | 0.110 |
Why?
| | Culture Media, Conditioned | 1 | 2015 | 112 | 0.110 |
Why?
| | Aging | 2 | 2021 | 1992 | 0.110 |
Why?
| | Immunoblotting | 1 | 2015 | 296 | 0.110 |
Why?
| | Collagen Type VI | 1 | 2014 | 5 | 0.110 |
Why?
| | Sex Factors | 2 | 2026 | 2136 | 0.110 |
Why?
| | Hexuronic Acids | 1 | 2014 | 29 | 0.110 |
Why?
| | Polysaccharide-Lyases | 1 | 2014 | 11 | 0.110 |
Why?
| | Glucuronic Acid | 1 | 2014 | 30 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 435 | 0.110 |
Why?
| | Mice, Inbred C3H | 1 | 2014 | 254 | 0.100 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2015 | 203 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2974 | 0.100 |
Why?
| | Arterial Pressure | 1 | 2015 | 134 | 0.100 |
Why?
| | Mitochondrial Dynamics | 1 | 2014 | 41 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2010 | 459 | 0.100 |
Why?
| | Propylene Glycols | 2 | 2014 | 28 | 0.100 |
Why?
| | Dehydroepiandrosterone | 1 | 2014 | 49 | 0.100 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2014 | 75 | 0.100 |
Why?
| | HMGB1 Protein | 1 | 2014 | 51 | 0.100 |
Why?
| | Ligands | 3 | 2023 | 675 | 0.100 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2013 | 55 | 0.100 |
Why?
| | Mutation | 2 | 2026 | 4130 | 0.100 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2016 | 248 | 0.100 |
Why?
| | Paracrine Communication | 1 | 2014 | 67 | 0.100 |
Why?
| | Metabolome | 1 | 2017 | 391 | 0.100 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2013 | 50 | 0.100 |
Why?
| | Oligopeptides | 2 | 2014 | 267 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 196 | 0.100 |
Why?
| | Glycolysis | 1 | 2015 | 341 | 0.100 |
Why?
| | Glycerylphosphorylcholine | 1 | 2013 | 5 | 0.100 |
Why?
| | Calpain | 1 | 2013 | 61 | 0.100 |
Why?
| | Virulence | 1 | 2014 | 287 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 441 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2006 | 552 | 0.100 |
Why?
| | Bronchitis, Chronic | 1 | 2013 | 16 | 0.090 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2013 | 31 | 0.090 |
Why?
| | Cattle | 3 | 2008 | 948 | 0.090 |
Why?
| | Hyperoxia | 1 | 2015 | 127 | 0.090 |
Why?
| | Dermatitis, Contact | 1 | 2013 | 18 | 0.090 |
Why?
| | Platelet Activating Factor | 1 | 2013 | 45 | 0.090 |
Why?
| | MAP Kinase Signaling System | 2 | 2012 | 308 | 0.090 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2013 | 46 | 0.090 |
Why?
| | Lung Compliance | 1 | 2012 | 42 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2223 | 0.090 |
Why?
| | Proteolysis | 1 | 2013 | 173 | 0.090 |
Why?
| | United States | 4 | 2024 | 16313 | 0.090 |
Why?
| | Neuralgia | 1 | 2014 | 140 | 0.090 |
Why?
| | HIV Infections | 3 | 2017 | 3235 | 0.090 |
Why?
| | Drug Tolerance | 2 | 2009 | 99 | 0.090 |
Why?
| | Estrogen Antagonists | 1 | 2012 | 37 | 0.090 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 64 | 0.090 |
Why?
| | Liposomes | 1 | 2014 | 268 | 0.090 |
Why?
| | Airway Remodeling | 1 | 2012 | 63 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 440 | 0.090 |
Why?
| | Atmosphere Exposure Chambers | 1 | 2011 | 6 | 0.090 |
Why?
| | Cardiac Output | 1 | 2012 | 179 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2014 | 1302 | 0.090 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 6011 | 0.090 |
Why?
| | Catalase | 1 | 2011 | 134 | 0.080 |
Why?
| | Polymerase Chain Reaction | 2 | 2015 | 1046 | 0.080 |
Why?
| | Goblet Cells | 1 | 2011 | 22 | 0.080 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2011 | 149 | 0.080 |
Why?
| | Bronchioles | 1 | 2011 | 29 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2013 | 394 | 0.080 |
Why?
| | Immunization, Passive | 1 | 2011 | 90 | 0.080 |
Why?
| | Permeability | 1 | 2011 | 170 | 0.080 |
Why?
| | Microcirculation | 1 | 2011 | 142 | 0.080 |
Why?
| | Ceramidases | 1 | 2010 | 4 | 0.080 |
Why?
| | Inflammasomes | 1 | 2012 | 145 | 0.080 |
Why?
| | Phosphorylation | 1 | 2015 | 1721 | 0.080 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 232 | 0.080 |
Why?
| | Acetylcysteine | 1 | 2011 | 139 | 0.080 |
Why?
| | Plant Extracts | 1 | 2012 | 191 | 0.080 |
Why?
| | Jurkat Cells | 1 | 2010 | 115 | 0.080 |
Why?
| | Mice, Inbred Strains | 1 | 2011 | 397 | 0.080 |
Why?
| | Carcinogens | 1 | 2011 | 123 | 0.080 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2010 | 56 | 0.080 |
Why?
| | Stem Cells | 1 | 2015 | 630 | 0.080 |
Why?
| | Testosterone | 1 | 2014 | 417 | 0.080 |
Why?
| | Analgesics, Opioid | 2 | 2009 | 1167 | 0.080 |
Why?
| | Transplantation, Heterologous | 1 | 2010 | 170 | 0.080 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 51 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 949 | 0.080 |
Why?
| | Perfusion | 1 | 2011 | 252 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 2014 | 568 | 0.070 |
Why?
| | Posterior Horn Cells | 1 | 2009 | 10 | 0.070 |
Why?
| | Biosensing Techniques | 1 | 2011 | 142 | 0.070 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2012 | 430 | 0.070 |
Why?
| | Exercise | 1 | 2022 | 2219 | 0.070 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1730 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2017 | 2812 | 0.070 |
Why?
| | Pulmonary Circulation | 1 | 2011 | 434 | 0.070 |
Why?
| | Clathrin | 1 | 2009 | 26 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2013 | 698 | 0.070 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 90 | 0.070 |
Why?
| | Oxidation-Reduction | 3 | 2022 | 1077 | 0.070 |
Why?
| | Transplantation Tolerance | 1 | 2009 | 39 | 0.070 |
Why?
| | Transplantation, Homologous | 1 | 2010 | 422 | 0.070 |
Why?
| | Peroxynitrous Acid | 1 | 2008 | 11 | 0.070 |
Why?
| | Immunosuppressive Agents | 2 | 2014 | 840 | 0.070 |
Why?
| | Histocompatibility Antigens | 1 | 2009 | 102 | 0.070 |
Why?
| | Protein Precursors | 1 | 2009 | 136 | 0.070 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2006 | 103 | 0.070 |
Why?
| | Transcription, Genetic | 2 | 2013 | 1456 | 0.070 |
Why?
| | Cell Line, Tumor | 3 | 2011 | 3565 | 0.070 |
Why?
| | Superoxide Dismutase-1 | 1 | 2008 | 13 | 0.070 |
Why?
| | Pyrroles | 1 | 2009 | 221 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 840 | 0.070 |
Why?
| | Software | 1 | 2013 | 683 | 0.070 |
Why?
| | Cyclosporine | 1 | 2009 | 257 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 264 | 0.070 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2008 | 52 | 0.070 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2020 | 274 | 0.070 |
Why?
| | Patch-Clamp Techniques | 1 | 2009 | 289 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 254 | 0.070 |
Why?
| | Glycerophospholipids | 2 | 2018 | 39 | 0.070 |
Why?
| | Transglutaminases | 1 | 2008 | 159 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2009 | 364 | 0.070 |
Why?
| | Caspase 9 | 2 | 2008 | 55 | 0.060 |
Why?
| | Superoxides | 1 | 2008 | 199 | 0.060 |
Why?
| | Antibody Formation | 1 | 2008 | 288 | 0.060 |
Why?
| | Obesity | 2 | 2020 | 3149 | 0.060 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 338 | 0.060 |
Why?
| | Organ Size | 1 | 2008 | 465 | 0.060 |
Why?
| | Cell-Free System | 1 | 2006 | 54 | 0.060 |
Why?
| | Antiviral Agents | 2 | 2023 | 776 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2020 | 2627 | 0.060 |
Why?
| | Cisplatin | 1 | 2008 | 347 | 0.060 |
Why?
| | Graft Rejection | 1 | 2009 | 523 | 0.060 |
Why?
| | Indoles | 1 | 2009 | 510 | 0.060 |
Why?
| | Capillaries | 1 | 2006 | 125 | 0.060 |
Why?
| | Fumonisins | 1 | 2005 | 3 | 0.060 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 1195 | 0.060 |
Why?
| | Hepatocytes | 1 | 2026 | 224 | 0.060 |
Why?
| | Adenoviridae | 1 | 2006 | 199 | 0.050 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2005 | 55 | 0.050 |
Why?
| | Antigens, CD | 2 | 2011 | 562 | 0.050 |
Why?
| | Blood Pressure | 1 | 2012 | 1785 | 0.050 |
Why?
| | Acyltransferases | 1 | 2005 | 78 | 0.050 |
Why?
| | Deoxyguanosine | 1 | 2004 | 25 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1798 | 0.050 |
Why?
| | Regeneration | 1 | 2006 | 198 | 0.050 |
Why?
| | Disease Progression | 1 | 2012 | 2892 | 0.050 |
Why?
| | Weight Loss | 1 | 2010 | 867 | 0.050 |
Why?
| | Immunoglobulin G | 1 | 2008 | 901 | 0.050 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 19 | 0.050 |
Why?
| | Supreme Court Decisions | 1 | 2023 | 12 | 0.050 |
Why?
| | Stress Fibers | 1 | 2003 | 18 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2003 | 80 | 0.050 |
Why?
| | Adherens Junctions | 1 | 2003 | 24 | 0.050 |
Why?
| | Caspase 8 | 1 | 2003 | 48 | 0.050 |
Why?
| | Myosins | 1 | 2003 | 132 | 0.050 |
Why?
| | rho-Associated Kinases | 1 | 2003 | 82 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 398 | 0.040 |
Why?
| | Ovarian Neoplasms | 1 | 2008 | 599 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1514 | 0.040 |
Why?
| | Imidazoles | 1 | 2003 | 247 | 0.040 |
Why?
| | Cell Communication | 1 | 2023 | 329 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 367 | 0.040 |
Why?
| | Epithelium | 1 | 2022 | 311 | 0.040 |
Why?
| | Autophagosomes | 1 | 2021 | 20 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2023 | 373 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2679 | 0.040 |
Why?
| | Autoantibodies | 1 | 2008 | 1513 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.040 |
Why?
| | Fever | 1 | 2022 | 320 | 0.040 |
Why?
| | Antineoplastic Agents | 2 | 2009 | 2231 | 0.040 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2020 | 7 | 0.040 |
Why?
| | Transcription Factor RelA | 1 | 2020 | 93 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 122 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 751 | 0.040 |
Why?
| | Neurons | 1 | 2008 | 1672 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2023 | 731 | 0.040 |
Why?
| | Rats, Inbred WKY | 2 | 2009 | 35 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2020 | 572 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 121 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2020 | 361 | 0.040 |
Why?
| | Pyridines | 1 | 2003 | 610 | 0.040 |
Why?
| | Swine | 1 | 2021 | 828 | 0.030 |
Why?
| | Cell Lineage | 1 | 2020 | 381 | 0.030 |
Why?
| | Propensity Score | 1 | 2020 | 379 | 0.030 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2018 | 21 | 0.030 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2018 | 27 | 0.030 |
Why?
| | Cohort Studies | 2 | 2020 | 6099 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2020 | 267 | 0.030 |
Why?
| | Propionates | 1 | 2018 | 39 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2022 | 538 | 0.030 |
Why?
| | Odds Ratio | 1 | 2020 | 1084 | 0.030 |
Why?
| | Vital Capacity | 1 | 2018 | 293 | 0.030 |
Why?
| | Protein Stability | 1 | 2018 | 176 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 288 | 0.030 |
Why?
| | Nitriles | 1 | 2018 | 211 | 0.030 |
Why?
| | Sample Size | 1 | 2017 | 124 | 0.030 |
Why?
| | RNA | 1 | 2023 | 916 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1496 | 0.030 |
Why?
| | HIV | 1 | 2017 | 251 | 0.030 |
Why?
| | Weight Gain | 1 | 2020 | 566 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 117 | 0.030 |
Why?
| | Antioxidants | 2 | 2013 | 550 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1845 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 886 | 0.030 |
Why?
| | NF-kappa B | 2 | 2010 | 676 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2142 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 387 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.030 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2015 | 79 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2015 | 172 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 61 | 0.030 |
Why?
| | Physical Endurance | 1 | 2016 | 279 | 0.030 |
Why?
| | Interleukin-23 Subunit p19 | 1 | 2014 | 6 | 0.030 |
Why?
| | Quinazolinones | 1 | 2014 | 18 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 132 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 107 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 1051 | 0.030 |
Why?
| | Indans | 1 | 2014 | 13 | 0.030 |
Why?
| | Oxadiazoles | 1 | 2014 | 37 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 143 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2016 | 242 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2015 | 319 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 545 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 369 | 0.030 |
Why?
| | Anilides | 1 | 2014 | 84 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 14437 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 575 | 0.030 |
Why?
| | Phosphatidylserines | 1 | 2014 | 62 | 0.030 |
Why?
| | Organophosphonates | 1 | 2014 | 95 | 0.020 |
Why?
| | Thiophenes | 1 | 2014 | 117 | 0.020 |
Why?
| | Thiazoles | 1 | 2014 | 142 | 0.020 |
Why?
| | Cricetulus | 1 | 2013 | 118 | 0.020 |
Why?
| | CHO Cells | 1 | 2013 | 169 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2020 | 853 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2022 | 17561 | 0.020 |
Why?
| | Dinitrofluorobenzene | 1 | 2013 | 4 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2014 | 131 | 0.020 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 2013 | 24 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 616 | 0.020 |
Why?
| | Lipid Bilayers | 1 | 2014 | 104 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1912 | 0.020 |
Why?
| | Culture Media, Serum-Free | 1 | 2012 | 42 | 0.020 |
Why?
| | Hydrolases | 1 | 2013 | 41 | 0.020 |
Why?
| | Lymphocyte Depletion | 1 | 2013 | 133 | 0.020 |
Why?
| | Chemokine CXCL10 | 1 | 2012 | 39 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 169 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2013 | 167 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2015 | 915 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2015 | 507 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 590 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 334 | 0.020 |
Why?
| | Tyrosine | 1 | 2012 | 218 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 210 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2020 | 1253 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 1018 | 0.020 |
Why?
| | Metaplasia | 1 | 2011 | 57 | 0.020 |
Why?
| | Mucus | 1 | 2011 | 75 | 0.020 |
Why?
| | Th2 Cells | 1 | 2011 | 179 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2014 | 566 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 2017 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2009 | 105 | 0.020 |
Why?
| | Rats, Inbred BN | 1 | 2009 | 56 | 0.020 |
Why?
| | Blood Glucose | 1 | 2020 | 2359 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 415 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2009 | 77 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 123 | 0.020 |
Why?
| | Transplantation, Isogeneic | 1 | 2008 | 17 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2526 | 0.020 |
Why?
| | Spleen | 1 | 2011 | 509 | 0.020 |
Why?
| | X-Linked Inhibitor of Apoptosis Protein | 1 | 2008 | 9 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2009 | 247 | 0.020 |
Why?
| | Isoxazoles | 1 | 2008 | 56 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2008 | 125 | 0.020 |
Why?
| | GTP-Binding Proteins | 1 | 2008 | 153 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1504 | 0.020 |
Why?
| | Administration, Oral | 1 | 2009 | 874 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 1046 | 0.010 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2009 | 939 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2018 | 8432 | 0.010 |
Why?
| | Pleura | 1 | 2005 | 28 | 0.010 |
Why?
| | Ligation | 1 | 2005 | 91 | 0.010 |
Why?
| | Algorithms | 1 | 2013 | 1868 | 0.010 |
Why?
| | Postural Balance | 1 | 2008 | 254 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2004 | 120 | 0.010 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 113 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 409 | 0.010 |
Why?
| | Endopeptidases | 1 | 2003 | 80 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2008 | 878 | 0.010 |
Why?
| | Pulmonary Embolism | 1 | 2005 | 246 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2011 | 2017 | 0.010 |
Why?
| | Peptides | 1 | 2008 | 1003 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 11947 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1772 | 0.010 |
Why?
| | Child | 1 | 2017 | 22980 | 0.010 |
Why?
|
|
Petrache's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|